Related Experiment Videos
Non-ergot dopamine agonist-induced sleep attacks
1Division of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, USA.
Pharmacotherapy
|June 15, 2000
Abstract:
Two patients with Parkinson's disease received treatment with ropinirole and/or pramipexole, during which both experienced sleep attacks. These attacks may be a class effect of non-ergot dopamine agonists. Health care professionals should be aware of the potential of these agents to cause sleep attacks and caution patients about this potentially life-threatening adverse effect.